FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On November 15, 2004
Table of Contents
Docket # Title
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2003D-0290 Compounding of Drugs for Use in Animals Compliance Policy Guide
2003P-0176 Follow-Up Approval of Therapeutic Protein Products
2003P-0574 Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
2004D-0343 Hospital Bed System Dimensional Guidance to Reduce Entrapment
2004D-0377 International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
2004F-0066 Filing of Food Additive Petition (FAP 4A4754) Food Additives Permitted in Food on an Interim Basis or in Contact With Food Pending Additional Study; Mannitol
2004N-0264 Federal Measures to Mitigate BSE Risks: Considerations for Further Action
2004N-0355 Scientific Considerations Related to Developing Follow-on Protein Products
2004P-0171 Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
2004P-0231 Deny approval of NDA 21-426 for Ominitrop 5.8 mg somatropin [ rDNA origin ] for injection, lyophilized powder and diluent with preservative
2004P-0349 Action on Products containing added Mercury
2004V-0505 Laser Light Show
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
SF 9 GCF-1 Vol #: 444
2003D-0290 Compounding of Drugs for Use in Animals Compliance Policy Guide
C 11 K and J Roach Vol #: 1
2003P-0176 Follow-Up Approval of Therapeutic Protein Products
C 2 Barr Laboratories, Inc. Vol #: 2
2003P-0574 Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
C 9 WEBB Consulting, LLC Vol #: 2
2004D-0343 Hospital Bed System Dimensional Guidance to Reduce Entrapment
C 2 Bed Safety Consulting, Inc. Vol #: 1
2004D-0377 International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
C 2 GlaxoSmithKline Vol #: 1
2004F-0066 Filing of Food Additive Petition (FAP 4A4754) Food Additives Permitted in Food on an Interim Basis or in Contact With Food Pending Additional Study; Mannitol
BKG 1
Reference 2, 3
Background Vol #: 1
2004N-0264 Federal Measures to Mitigate BSE Risks: Considerations for Further Action
C 194 Pet Food Institute Vol #: 23
2004N-0355 Scientific Considerations Related to Developing Follow-on Protein Products
C 3 Amgen, Inc. (Amgen) Vol #: 1
C 4 Pharmaceutical Research and Manufacturers of America (PhRMA) Vol #: 1
C 5 Sicor, Inc. Vol #: 1
C 6 Pfizer, Inc. Vol #: 1
2004P-0171 Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
C 5 Barr Laboratories, Inc. Vol #: 1
C 6 Pharmaceutical Research and Manufacturers of America (PhRMA) Vol #: 1
2004P-0231 Deny approval of NDA 21-426 for Ominitrop 5.8 mg somatropin [ rDNA origin ] for injection, lyophilized powder and diluent with preservative
C 2 Barr Laboratories, Inc. Vol #: 1
LET 1 HFD-005 to Morgan Lewis & Bocklus LLP Vol #: 1
2004P-0349 Action on Products containing added Mercury
SUP 1 Coalition for Mercury-free Drugs (CoMeD) Vol #: 1
2004V-0505 Laser Light Show
ACK 1 HFA-305 to XEFX Productions Vol #: 1
VAR 1 XEFX Productions Vol #: 1

Page created on November 16, 2004 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management